The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA1c in pediatric type 1 diabetic patients

Diabetes Care

Volumn 25, Issue 10, 2002, Pages 1840-1844

  Salardi, Silvana ^a,b   Zucchini, Stefano ^a   Santoni, Roberta ^a   Ragni, Luca ^a   Gualandi, Stefano ^a   Cicognani, Alessandro ^a   Cacciari, Emanuele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Clinica Pediatrica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; BIOLOGICAL MARKER; FRUCTOSAMINE; GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CHILD; CLINICAL ARTICLE; CORRELATION ANALYSIS; GLUCOSE BLOOD LEVEL; GLYCATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; METABOLIC REGULATION; POSTPRANDIAL STATE; AMBULATORY MONITORING; AREA UNDER THE CURVE; BLOOD; FEMALE; METABOLISM; METHODOLOGY; REPRODUCIBILITY;

ADOLESCENT; AREA UNDER CURVE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; FRUCTOSAMINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MONITORING, AMBULATORY; REPRODUCIBILITY OF RESULTS;

EID: 0036780619     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.10.1840     Document Type: Article

References (13)

1. Bode BW, Gross TM, Thornton KR, Mastrototaro JJ: Continuous glucose monitoring used to adjust diabetes therapy improved glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract 46:183-190, 1999
2. Mastrototaro J: The MiniMed continuous glucose monitoring system (CGMS). J Pediatr Endocrinol Metab 12:751-758, 1999
3. Bode WB, Hirsch IB: Using the continuous glucose monitoring system to improve the management of type 1 diabetes. Diabetes Technol Ther 2 (Suppl.):S43-S48, 2000
4. Chase HP, Kim LM, Owen SL, MacKenzie TA, Klingensmith GJ, Murtfeld R, Garg SK: Continuous subcutaneous glucose monitoring in children with type 1 diabetes. Pediatrics 107:222-226, 2001
5. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV: Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 24:1858-1862, 2001
6. Kaufman FR, Gibson LC, Halvorson M, Carpenter S, Fisher LK, Pitukcheewanont P: A pilot study of the continuous glucose monitoring system: clinical decision and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care 24:2030-2034, 2001
7. 1c values with average blood glucose values in a pie chart form. Diabetes Care 21:209-212, 1998
8. Kovatchev BP, Cox DJ, Farthy LS, Straume M, Gonder-Frederick L, Clarke WL: Episodes of severe hypoglycemia in type 1 diabetes are preceded and followed within 48 hours by measurable disturbances in blood glucose. J Clin Endocrinol Metab 85:4287-4292, 2000
9. 1c. Diabetes Care 23:1236-1241, 2000
10. de Veciana M, Major CA, Morgan MA, Asrat T, Toohey JS, Lien JM, Evans AT: Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 333:1237-1241, 1995
11. Shaw JE, Hodge AM, de Courten M, Chitson P, Zimmet PZ: Isolated post-challenge hyperglycemia confirmed as a risk factor for mortality. Diabetologia 42:1050-1054, 1999
12. Shichiri M, Kishikawa H, Ohkubo Y, Wake N: Long term results of the Kumamoto Study on optimal diabetes control in type 2 diabetes patients. Diabetes Care 23 (Suppl. 2):B21-B29, 2000
13. Ceriello A: The post-prandial state and cardiovascular disease: relevance to diabetes mellitus. Diabetes Metab Rev 16:125-132, 2000